Posted by Nick Hanson (@nickhanson) · May 7, 2012
Group Aims to Close Credibility Gap in Publishing Industry-Sponsored Research
ROCHESTER, Minn. — May 7, 2012. The Medical Publishing Insights and Practices (MPIP) initiative and its co-sponsors recently collaborated with journal editors to characterize the persistent and perceived credibility gap in reporting industry-sponsored research and to identify potential approaches to resolve it. This unique round table, hosted by MPIP, reached consensus on Ten Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research as reported in the May issue of Mayo Clinic Proceedings.
Attendees of the roundtable agreed that important improvements have been made in the conduct and reporting of industry-sponsored studies during the last five years, but several opportunities remain for additional improvement. These include ensuring that clinical studies and publications address clinically important questions; making public all results, including negative or unfavorable ones in a timely fashion, while avoiding redundancy; and exhibiting zero tolerance for selective or biased disclosure of research results, ghostwriting and guest authorship, and inaccurate or incomplete reporting of potential conflicts of interest.
"Intended as a 'call to action' for all stakeholders, these recommendations provide a road map for authors, editors, and publishers to improve standards applicable to all medical research studies and publications by highlighting critical areas that merit attention in terms of policies, education, and other activities," notes Maja Zecevic, Ph.D., MPH, corresponding author of the paper and North American senior editor of The Lancet.
"We are extremely pleased to publish this important set of recommendations in Mayo Clinic Proceedings," says Editor-in-Chief William Lanier, M.D. "Although framed in the context of industry sponsorship, many of these recommendations are more widely applicable to enhance the credibility of clinical research publications in general, regardless of the funding source."
MPIP was founded in 2008 by members of the pharmaceutical industry and the International Society for Medical Publication Professionals (ISMPP) to elevate trust, transparency, and integrity in publishing industry-sponsored studies. MPIP seeks to promote more effective partnership between sponsors and journals to raise standards in medical publishing and expand access to study results. To date, MPIP has identified issues perceived by journals to be barriers to transparency and trust and collaborated with journal editors and publishers on actionable solutions and resources. MPIP is a collaboration co-sponsored by Amgen, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Janssen, Merck, Pfizer, Takeda, and ISMPP.
About Mayo Clinic:
Recognizing 150 years of serving humanity in 2014, Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit 150years.mayoclinic.org, http://www.mayoclinic.org and newsnetwork.mayoclinic.org.
Media Contact: Nick Hanson, 507-284-5005 (days), firstname.lastname@example.org